Brigit Biofarmaka Teknologi Tbk. vs Pakuan Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Pakuan Tbk. trades at Rp3,790 (market cap 4.97T, 1.84M 24h volume). The key difference: Pakuan Tbk. is far larger — about 29.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Pakuan Tbk. is more actively traded (1.84M versus 324K). Which is the better fit depends on your goals.
| OBAT | UANG | |
|---|---|---|
Market Cap | 166.01B | 4.97T |
Volume | 324K | 1.84M |
Lot | 3.24K | 18.41K |
Turnover | 77.68M | 7.06B |
Average Price | 239.75 | 3,833.97 |
Value | 77.68M | 7.06B |
Indicative Equilibrium Price | 240 | 3,790 |
Indicative Equilibrium Volume | 1 | 690 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Pakuan Tbk (Company) was established based on the Deed No.21, dated March 08, 1971 of Ridwan Suselo, S.H., notary in Jakarta. The company began operations commercially since 1973
Read more on UANG →